We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
-$31.8M
Cap. Flow %
-0.9%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
0.8 quarters
Top 20 Avg Time Held Equity + Options
1.2 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.8 quarters
Top 20 Avg Time Held Equity only
1.2 quarters

Top Buys

Rank Stock Value
1
HCP icon
HashiCorp, Inc. Class A Common Stock
HCP
+$138M
2
ETRN icon
Equitrans Midstream Corporation Common Stock
ETRN
+$131M
3
EDR icon
Endeavor Group Holdings, Inc.
EDR
+$127M
4
MRO icon
Marathon Oil Corporation
MRO
+$123M
5
CHX icon
ChampionX
CHX
+$98.3M

Top Sells

Rank Stock Value
1
PXD icon
Pioneer Natural Resource Co.
PXD
+$638M
2
CERE icon
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$51.2M
3
DFS icon
Discover Financial Services
DFS
+$45.1M
4
SCRM icon
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$18.4M
5
NSC icon
Norfolk Southern
NSC
+$17.7M

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Miscellaneous 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MRUS icon
351
DELISTED
Merus
MRUS
$533K 0.02%
9,000
-22,642
-72% -$1.1M
2022 Q1
9 quarters
ITOS icon
352
DELISTED
iTeos Therapeutics
ITOS
$524K 0.01%
+35,323
New +$506K
2024 Q2
0 quarters
EPR icon
353
EPR Properties
EPR
$4.19B
$512K 0.01%
12,200
+5,600
+85% +$230K
2024 Q1
1 quarter
RIG icon
354
PUT
Transocean
RIG
$6.15B
$496K 0.01%
403,400
-425,000
-51% -$2.46M
2018 Q2
24 quarters
LCID icon
355
Lucid Motors
LCID
$1.49B
$496K 0.01%
+19,010
New +$507K
2024 Q2
0 quarters
ALGN icon
356
Align Technology
ALGN
$10.1B
$491K 0.01%
+2,034
New +$566K
2024 Q2
0 quarters
PCVX icon
357
Vaxcyte
PCVX
$10.6B
$476K 0.01%
6,307
+300
+5% +$20.4K
2023 Q3
3 quarters
NNN icon
358
NNN REIT
NNN
$7.72B
$470K 0.01%
11,038
+338
+3% +$14.1K
2021 Q4
10 quarters
ICLR icon
359
Icon
ICLR
$12.7B
$468K 0.01%
1,492
+520
+53% +$163K
2024 Q1
1 quarter
COO icon
360
Cooper Companies
COO
$10.3B
$462K 0.01%
5,289
+100
+2% +$9.34K
2024 Q1
1 quarter
JD icon
361
JD.com
JD
$36.6B
$452K 0.01%
+17,500
New +$513K
2024 Q2
0 quarters
ETSY icon
362
Etsy
ETSY
$7.04B
$442K 0.01%
7,500
-55,000
-88% -$3.52M
2024 Q1
1 quarter
AFRM icon
363
Affirm
AFRM
$27.2B
$438K 0.01%
14,500
-4,000
-22% -$128K
2024 Q1
1 quarter
ROKU icon
364
Roku
ROKU
$22.7B
$420K 0.01%
+7,000
New +$410K
2024 Q2
0 quarters
AMC icon
365
AMC Entertainment Holdings
AMC
$2.66B
$388K 0.01%
77,868
-29,887
-28% -$120K
2023 Q3
3 quarters
SDGR icon
366
Schrodinger
SDGR
$2.04B
$387K 0.01%
20,011
-5,895
-23% -$136K
2022 Q1
9 quarters
MPT icon
367
PUT
Medical Properties Trust
MPT
$1.88B
$383K 0.01%
+396,500
New +$1.9M
2024 Q2
0 quarters
NCLH icon
368
PUT
Norwegian Cruise Line
NCLH
$7.15B
$371K 0.01%
233,800
– –
2021 Q2
12 quarters
HLF icon
369
PUT
Herbalife
HLF
$1.37B
$367K 0.01%
82,400
– –
2024 Q1
1 quarter
VSAT icon
370
PUT
Viasat
VSAT
$9.92B
$367K 0.01%
+73,300
New +$1.17M
2024 Q2
0 quarters
SLRN icon
371
DELISTED
ACELYRIN
SLRN
$359K 0.01%
81,412
+10,000
+14% +$46.9K
2023 Q4
2 quarters
SPT icon
372
Sprout Social
SPT
$667M
$357K 0.01%
10,000
-125,000
-93% -$5.03M
2023 Q4
2 quarters
ALGS icon
373
Aligos Therapeutics
ALGS
$33.3M
$350K 0.01%
40,000
+20,000
+100% +$352K
2024 Q1
1 quarter
CPRI icon
374
PUT
Capri Holdings
CPRI
$1.7B
$341K 0.01%
12,600
– –
2021 Q2
12 quarters
CHTR icon
375
PUT
Charter Communications
CHTR
$11.8B
$339K 0.01%
8,400
+5,000
+147% +$1.36M
2024 Q1
1 quarter
13 14
15
16 17

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.